Mark Zacur Net Worth

The estimated Net Worth of Mark P Zacur is at least $2.39 million dollars as of 3 June 2021. Mr. Zacur owns over 23,138 units of Owens & Minor stock worth over $1,045,674 and over the last 5 years he sold OMI stock worth over $1,343,420. In addition, he makes $0 as Senior Vice President et Chief Commercial Officer at Owens & Minor.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Zacur OMI stock SEC Form 4 insiders trading

Mark has made over 2 trades of the Owens & Minor stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 23,138 units of OMI stock worth $979,432 on 3 June 2021.

The largest trade he's ever made was selling 23,138 units of Owens & Minor stock on 3 June 2021 worth over $979,432. On average, Mark trades about 6,870 units every 5 days since 2020. As of 3 June 2021 he still owns at least 71,769 units of Owens & Minor stock.

You can see the complete history of Mr. Zacur stock trades at the bottom of the page.

Mark Zacur biography

Mark Zacur serves as Senior Vice President, Chief Commercial Officer of the Company. Mr. Zacur joined Owens & Minor in June 2019 and served as Senior Vice President & Chief Procurement Officer until November 2019. Prior to joining the company, Mr. Zacur served as Vice President & General Manager of Fisher Healthcare, a national diagnostics laboratory distributor and operating division of Thermo Fisher Scientific, from November 2014 to May 2019. Previously, he held a variety of marketing, product management, procurement and operations leadership roles at Thermo Fisher Scientific, Bayer Corporation and Reichhold Chemicals.

How old is Mark Zacur?

Mark Zacur is 57, he's been the Senior Vice President et Chief Commercial Officer of Owens & Minor since 2019. There are 9 older and 13 younger executives at Owens & Minor. The oldest executive at Owens & Minor, Inc. is Eddie Moore, 72, who is the Independent Director.

What's Mark Zacur's mailing address?

Mark's mailing address filed with the SEC is OWENS & MINOR, INC., 9120 LOCKWOOD BLVD, MECHANICSVILLE, VA, 23116.

Insiders trading at Owens & Minor

Over the last 21 years, insiders at Owens & Minor have traded over $85,847,692 worth of Owens & Minor stock and bought 130,089 units worth $2,231,834 . The most active insiders traders include Stuart Essig, Edward A Pesicka et Craig R Smith. On average, Owens & Minor executives and independent directors trade stock every 22 days with the average trade being worth of $213,276. The most recent stock trade was executed by Jonathan A Leon on 22 August 2024, trading 7,500 units of OMI stock currently worth $118,725.

What does Owens & Minor do?

owens & minor, inc. (nyse: omi) is a leading healthcare logistics company dedicated to connecting the world of medical products to the point of care by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. owens & minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. with logistics platforms strategically located in the united states and europe, owens & minor serves markets where three quarters of global healthcare spending occurs. owens & minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, and the federal government. a fortune 500 company, owens & minor is headquartered in richmond, virginia, and has annualized revenues exceeding $9 billion. for more information about owens & minor, visit the company website at www.owens-m

Complete history of Mr. Zacur stock trades at Owens & Minor

Owens & Minor executives and stock owners

Owens & Minor executives and other stock owners filed with the SEC include:

• Edward Pesicka,
  President, Chief Executive Officer, Director
• Edward A. Pesicka,
  Pres, CEO & Director
• Christopher Lowery,
  President - Global Products
• Andrew G. Long,
  Exec. VP & CFO
• Nicholas Pace,
  Executive Vice President, General Counsel, Corporate Secretary
• Christopher M. Lowery,
  Pres of Global Products
• Jeffrey T. Jochims,
  Exec. VP, COO & Pres of Medical Distribution
• Robert Sledd,
  Independent Chairman of the Board
• Michael Lowry,
  Senior Vice President, Corporate Controller, Chief Accounting Officer
• Mark McGettrick,
  Independent Director
• Eddie Moore,
  Independent Director
• Mark Beck,
  Independent Director
• Robert Henkel,
  Independent Director
• Michael Riordan,
  Independent Director
• Chuck Graves,
  Director - Finance & Investor Relations
• Gwendolyn Bingham,
  Independent Director
• Mark Zacur,
  Senior Vice President, Chief Commercial Officer
• David Myers,
  Senior Vice President, Chief Procurement Officer
• Jonathan Leon,
  Senior Vice President, Corporate Treasurer
• Shana Neal,
  Chief Human Resource Officer, Executive Vice President
• Jeffrey Jochims,
  Chief Operating Officer, Executive Vice President
• Andrew Long,
  Chief Financial Officer, Executive Vice President
• Mark P. Zacur,
  Exec. VP & Chief Commercial Officer
• Shana Carol Neal,
  Exec. VP & Chief HR Officer
• Nicholas Joseph Pace II,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Alex Jost CPA,
  Director of Investor Relations
• Michael Wayne Lowry,
  Sr. VP, Corp. Controller & Chief Accounting Officer
• Carissa Rollins,
  Director
• Aster Angagaw,
  Director
• Stephen W Klemash,
  Director
• Lemuel E Lewis,
  Director
• Martha H. Marsh,
  Director
• Stuart Raymond Morris Hipkins,
  President
• Richard A Meier,
  EVP, Chief Financial Officer
• Rony Camil Kordahi,
  EVP, North American Operations
• Geoff Taylor Marlatt,
  SVP, Manufacturer Services
• Michael Jay Romans,
  SVP, Human Resources
• Richard W Mears,
  Sr. VP, CIO
• Charles C Colpo,
  Senior Vice President
• Craig R Smith,
  President & COO
• Stuart Essig,
  Director
• Stephen Russell Olive,
  SVP, Chief Information Officer
• Erika T Davis,
  Senior. Vice President
• John W Gerdelman,
  Director
• David S Simmons,
  Director
• James E Rogers,
  Director
• Barbara B Hill,
  Director
• Paul Cody Phipps,
  President & CEO
• Timothy P Connolly,
  EVP, Operations & Supply Chain
• Joseph S Pekala,
  SVP, Chief Information Officer
• Robert K Snead,
  EVP, CFO
• Henry A Berling,
  Executive Vice President
• David R Guzman,
  Senior Vice President
• Vernard W Henley,
  Director
• Timothy J Callahan,
  Senior Vice President
• D Andrew Edwards,
  Vice President, Finance
• Daniel Todd Healy,
  SVP, Provider Services
• William Marshall Simpson,
  Group Vice President,
• Jeffrey Kaczka,
  Senior Vice President
• Brian J Shotto,
  SVP, Specialty Services
• Scott W Perkins,
  Senior Vice President
• James B Jr Farinholt,
  Director
• Ev Iii Clarke,
  Group VP, Sales & Distribution
• Richard F Bozard,
  Vice President
• Olwen B Cape,
  Vice President
• J Alfred Jr Broaddus,
  Director
• James E Ukrop,
  Director
• G Gilmer Iii Minor,
  Chairman & CEO
• John T Crotty,
  Director
• Grace R Denttartog,
  Senior Vice President
• A Marshall Acuff,
  Director
• Peter S Redding,
  Director
• James L Bierman,
  SVP, Chief Finanical Officer
• Sumeren Mark A Van,
  Senior Vice President
• Richard E Fogg,
  Director
• Anne M Whittemore,
  Director
• Kenneth Gardner Smith,
  Director
• Tammy L Gomez,
  EVP, CHRO
• Perry A Bernocchi,
  EVP, CEO,. Patient Direct
• Daniel J Starck,
  EVP, Business Excellence
• Alexander J Bruni,
  EVP, CFO
• Heath H Galloway,
  EVP,General Counsel & CorpSecy
• Rita Johnson Mills,
  Director
• Teresa L. Kline,
  Director
• Jennifer A Stone,
  EVP, CHRO
• Snehashish Sarkar,
  EVP, Chief Information Officer